In Vertigo Vertigo means a spinning sensation or dizziness that is triggered due to frequent movement. It can happen due to many reasons but it may also occur without any underlying disease. Pyrinate 25mg/50mg Tablet helps treat this sensation effectively. If you feel dizzy while getting up from the bed, sit for a while and then rise slowly to avoid having an accidental fall. In Motion sickness Motion sickness is a condition caused due to motion during travel. You may experience spinning sensation (vertigo), nausea or vomiting as a result of this condition. Pyrinate 25mg/50mg Tablet helps treat these symptoms effectively. Take it as prescribed by the doctor to get maximum benefit.
Caution is advised when consuming alcohol with Pyrinate 25mg/50mg Tablet. Please consult your doctor.
Pyrinate 25mg/50mg Tablet is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Pyrinate 25mg/50mg Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby. Larger doses or prolonged use of Pyrinate 25mg/50mg Tablet may cause sleepiness and other effects in the baby
Pyrinate 25mg/50mg Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Pyrinate 25mg/50mg Tablet is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Pyrinate 25mg/50mg Tablet may not be needed in these patients. Please consult your doctor.
Pyrinate 25mg/50mg Tablet is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Pyrinate 25mg/50mg Tablet may not be needed in these patients. Please consult your doctor.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Votary Laboratories I Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Welfo Pharmaceuticals Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Remedial Healthcare || ₹14.5/tablet (25% cheaper)